Table 4.
Comparison of plans to APBI-3DCRT-FB to evaluate the impact of patient geometry for all PBI techniques.
| APBI3DCRT with FB | APBI3DCRT with DIBH | APBI IMRT with DIBH | |||
|---|---|---|---|---|---|
| N = 10 | Dose (Gy) |
Dose (Gy) |
P-value | Dose (Gy) |
P-value |
| PTV | |||||
| Maximum | 44.6 | 44.9 | 0.2437 | 41.5* | 0.0008 |
| Mean | 40.6 | 40.9 | 0.0414 | 39.1* | <0.0001 |
| %Vol>95%d | 99.6 | 99.1 | 0.4734 | 99.2 | 0.4072 |
| Heart | |||||
| Maximum | 8.2 | 4.8 | 0.0183 | 3.8 | 0.0523 |
| Mean | 0.5 | 0.4* | 0.0024 | 0.5 | 0.6827 |
| LAD | |||||
| Maximum | 6.1 | 2.2 | 0.1392 | 1.8 | 0.1505 |
| Mean | 1.9 | 0.7 | 0.1243 | 0.8 | 0.1610 |
| Left lung | |||||
| Maximum | 38.1 | 35.5* | 0.0135 | 35.4* | 0.0023 |
| Mean | 2.9 | 1.7* | 0.0001 | 1.8* | 0.0010 |
| V20 | 4.1 | 1.7* | <0.0001 | 1.4* | 0.0002 |
| V10 | 9.2 | 4.6* | 0.0004 | 4.0* | 0.0003 |
| V5 | 14.9 | 8.5* | 0.0007 | 8.2* | 0.0008 |
| Left Breast minus PTV | |||||
| Maximum | 44.5 | 44.8 | 0.3675 | 41.4* | 0.0008 |
| Mean | 18.3 | 17.0* | 0.0112 | 14.8* | 0.0002 |
| %Vol@50%d | 42.7 | 39.4* | 0.0446 | 37.2* | 0.0147 |
| Right Breast | |||||
| Maximum | 3.2 | 2.9 | 0.1211 | 1.8 | 0.2444 |
| Mean | 0.1 | 0.1 | 0.2114 | 0.1 | 0.0784 |
Denotes p-value <0.05.